Adam J. Schoenfeld

Also affiliated with Cornell University, Kettering University, Weill Cornell Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.258Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100759

Top 59%

0.258DataRank

Top 59%4 citations

Andrea Arfè, Biagio Ricciuti, Andréanne Gagné, Lynette M. Sholl, Alessandro Di Federico +19 more

Papers

Driven by 53 papers — median percentile 0. Top paper: “Non-viral precision T cell receptor replacement for personalized cell therapy”.

Non-viral precision T cell receptor replacement for personalized cell therapy

Nature(2022)10.1038/s41586-022-05531-1

N/A

4.1DataRank · unranked

281 citations

Kyle Jacoby, Daniela A. Bota, Theresa Hunter, Zheng Pan, Eric Stawiski +49 more

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3321

N/A

1.9DataRank · unranked

48 citations

Adam J. Schoenfeld, Evan Siau, Yue Christine Lu, Huichun Tai, Ken Suzawa +17 more

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

JAMA Oncology(2022)10.1001/jamaoncol.2022.5357

N/A

1.5DataRank · unranked

63 citations

Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih–Yuan Hsu +95 more

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-23912-4

N/A

1.1DataRank · unranked

34 citations

Adam J. Schoenfeld, Alex Makhnin, Yosef Y. Tobi, Yuli Wang, Heidie Frisco Cabanos +10 more

Acquired Resistance to Immune Checkpoint Inhibitors

Cancer Cell(2020)10.1016/j.ccell.2020.03.017

N/A

1.0DataRank · unranked

887 citations

Matthew D. Hellmann, Adam J. Schoenfeld

Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.10.004

N/A

0.941DataRank · unranked

34 citations

Erika Gedvilaite, Ryan Ptashkin, Jason C. Chang, John Ziegler, Douglas A. Mata +14 more

COVID-19 in patients with lung cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.06.007

N/A

0.840DataRank · unranked

270 citations

Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chai Bandlamudi +26 more

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Cancer Cell(2024)10.1016/j.ccell.2023.12.013

N/A

0.788DataRank · unranked

190 citations

Adam J. Schoenfeld, Darwin Ye, George Fromm, Hira Rizvi, Xiang H.-F. Zhang +28 more

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors

Cancer Cell(2022)10.1016/j.ccell.2022.08.022

N/A

0.717DataRank · unranked

118 citations

Elio Adib, Sarah Abou Alaiwi, Talal El Zarif, Stefan Groha, Elie W. Akl +27 more

Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0248

N/A

0.714DataRank · unranked

116 citations

Sai Ma, Lindsay M. LaFave, Arjun Bhutkar, Manyuan Liu, Lydia P. DeAngelo +18 more

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.07.005

N/A

0.701DataRank · unranked

106 citations

Joao V. Alessi, Arielle Elkrief, Xinan Wang, Alessio Cortellini, Y Y Li +27 more

Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.11.022

N/A

0.695DataRank · unranked

102 citations

Antonio Marra, Jane Sze Yin Sui, Jessica Flynn, Soo‐Ryum Yang, Christina J. Falcon +14 more

Deciphering radiological stable disease to immune checkpoint inhibitors

Annals of Oncology(2022)10.1016/j.annonc.2022.04.450

N/A

0.590DataRank · unranked

50 citations

Song Wu, Hira Rizvi, Q. Zhang, Jacklynn V. Egger, Juan C. Osorio +14 more

Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0498

N/A

0.564DataRank · unranked

42 citations

Nicholas R. Waters, Natalie Smith, Anqi Dai, John Slingerland, Nathan Aleynick +24 more

Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.01488

N/A

0.542DataRank · unranked

36 citations

Meagan Montesion, Smruthy Sivakumar, Caryn Hale, Anita S. Bowman, Ayyüce Begüm Bektaş +29 more

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1207

N/A

0.542DataRank · unranked

36 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Hira Rizvi, Arielle Elkrief +23 more

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC

Nature Communications(2023)10.1038/s41467-023-39874-8

N/A

0.515DataRank · unranked

30 citations

Biagio Ricciuti, Xinan Wang, Federica Pecci, Alessandro Di Federico, Giuseppe Lamberti +13 more

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

Annals of Oncology(2024)10.1016/j.annonc.2024.11.014

N/A

0.489DataRank · unranked

25 citations

Lingzhi Hong, Arielle Elkrief, Rohit Thummalapalli, Alissa J. Cooper, Biagio Ricciuti +43 more

Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer

Cell(2024)10.1016/j.cell.2024.11.010

N/A

0.449DataRank · unranked

19 citations

Maria Perry, Samuel I. Gould, Arielle Elkrief, Anton Safonov, Rohit Thummalapalli +23 more

Acquired resistance to PD-1 blockade in NSCLC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9621

N/A

0.425DataRank · unranked

16 citations

Hira Rizvi, Danish Memon, Jia Luo, Isabel R. Preeshagul, Jennifer L. Sauter +5 more

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006994

N/A

0.416DataRank · unranked

15 citations

Joao V. Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R. Preeshagul +16 more

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer

The Oncologist(2023)10.1093/oncolo/oyad197

N/A

0.385DataRank · unranked

12 citations

Biagio Ricciuti, Joao V. Alessi, Teng Fei, Hannah L. Kalvin, Jacklynn V. Egger +16 more

MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1 -Fusion-Positive Lung Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0025

N/A

0.373DataRank · unranked

11 citations

Igor Odintsov, Adam J. Schoenfeld, Evan Siau, Marissa S. Mattar, Elisa de Stanchina +7 more

Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.07.121

N/A

0.373DataRank · unranked

11 citations

Alessandro Di Federico, Bolun Liu, Alissa J. Cooper, Joao V. Alessi, Phoebe Clark +25 more

Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007618

N/A

0.330DataRank · unranked

8 citations

Adam Price, Allison L. Richards, Biagio Ricciuti, Xinan Wang, Arielle Elkrief +14 more

Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2990

N/A

0.312DataRank · unranked

7 citations

Rohit Thummalapalli, Stephanie Alden, Biagio Ricciuti, Joao V. Alessi, Arielle Elkrief +18 more

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1591

N/A

0.292DataRank · unranked

6 citations

Gilberto Lopes, T. Jeroen N. Hiltermann, Ramaswamy Govindan, Liza C. Villaruz, Emiliano Calvo +19 more

Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies

JAMA Oncology(2025)10.1001/jamaoncol.2024.5364

N/A

0.292DataRank · unranked

6 citations

Monica F. Chen, Anne Marie Noronha, Kristalla Panageas, Maggie Reynolds, Kaelyn Kohlasch +22 more

Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer

European Journal of Cancer(2024)10.1016/j.ejca.2024.114257

N/A

0.269DataRank · unranked

5 citations

Tatiana Erazo, Justin Jee, Andrea Arfè, Avantika Gupta, Luke Pike +28 more

Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100759

Top 59%

0.258DataRank

Top 59%4 citations

Andrea Arfè, Biagio Ricciuti, Andréanne Gagné, Lynette M. Sholl, Alessandro Di Federico +19 more

Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.02.017

N/A

0.165DataRank · unranked

2 citations

Jumanah N Algazaq, Kenneth Seier, Rhoena Desir-Camille, Li-Xuan Qin, Olayode Babatunde +12 more

Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9107

N/A

0DataRank · unranked

0 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Jia Luo, Joao Victor Machado Alessi +13 more

Data from Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung

(2023)10.1158/2159-8290.c.6549551

N/A

0DataRank · unranked

0 citations

Sai Ma, Lindsay M. LaFave, Arjun J. Bhutkar, Manyuan Liu, Lydia P. DeAngelo +18 more

Data from Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung

(2023)10.1158/2159-8290.c.6549551.v1

N/A

0DataRank · unranked

0 citations

Sai Ma, Lindsay M. LaFave, Arjun J. Bhutkar, Manyuan Liu, Lydia P. DeAngelo +18 more

CUT&RUN Supplementary Data from Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung

(2023)10.1158/2159-8290.22541093

Top 100%

0DataRank

Top 100%0 citations

Sai Ma, Lindsay M. LaFave, Arjun J. Bhutkar, Manyuan Liu, Lydia P. DeAngelo +18 more

Bulk ATAC-seq Supplementary Data from Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung

(2023)10.1158/2159-8290.22541096

Top 100%

0DataRank

Top 100%0 citations

Sai Ma, Lindsay M. LaFave, Arjun J. Bhutkar, Manyuan Liu, Lydia P. DeAngelo +18 more

CUT&RUN Supplementary Data from Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung

INDIGO (University of Illinois at Chicago)(2023)10.1158/2159-8290.22541093.v1

Top 100%

0DataRank

Top 100%0 citations

Sai Ma, Lindsay M. LaFave, Arjun J. Bhutkar, Manyuan Liu, Lydia P. DeAngelo +18 more

Supplementary Figures S1-S7 from Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung

INDIGO (University of Illinois at Chicago)(2023)10.1158/2159-8290.22541081.v1

N/A

0DataRank · unranked

0 citations

Sai Ma, Lindsay M. LaFave, Arjun J. Bhutkar, Manyuan Liu, Lydia P. DeAngelo +18 more

Impact of TMB, PD-L1 expression, and pneumonitis on outcomes to chemoradiation and durvalumab in unresectable stage III non-small cell lung cancers

Research Square(2022)10.21203/rs.3.rs-2273813/v1

N/A

0DataRank · unranked

0 citations

Biagio Ricciuti, Xinan Wang, Giuseppe Lamberti, Arielle Elkrief, Federica Pecci +12 more

Efficacy of PD-(L)1 blockade monotherapy compared to PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

medRxiv(2022)10.1101/2022.12.05.22283131

N/A

0DataRank · unranked

0 citations

Joao M. Victor Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R. Preeshagul +16 more

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patients with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab

JAMA Network Open(2023)10.1001/jamanetworkopen.2022.49591

N/A

0DataRank · unranked

23 citations

Annemarie F. Shepherd, Jordan Eichholz, Michael Offin, Daphna Y. Gelblum, Abraham J. Wu +9 more

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

medRxiv(2023)10.1101/2023.05.15.23289680

N/A

0DataRank · unranked

4 citations

Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam +23 more

Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1559

N/A

0DataRank · unranked

0 citations

Andrew Schroeder, Subrata Chatterjee, John Cadley, Christina J. Falcon, Miika Mehine +15 more

RNA-seq (cell line) Supplementary Data from Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung

INDIGO (University of Illinois at Chicago)(2023)10.1158/2159-8290.22541090.v1

Top 100%

0DataRank

Top 100%0 citations

Sai Ma, Lindsay M. LaFave, Arjun J. Bhutkar, Manyuan Liu, Lydia P. DeAngelo +18 more

Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008735

N/A

0DataRank · unranked

79 citations

Omid Hamid, Krishna V. Komanduri, Rodabe N. Amaria, Marcus O. Butler, John B.A.G. Haanen +6 more

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

Nature Communications(2024)10.1038/s41467-023-44512-4

N/A

0DataRank · unranked

33 citations

Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam +28 more

Association of the time of day of chemoradiotherapy and durvalumab with tumor control in lung cancer

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110658

N/A

0DataRank · unranked

3 citations

Annemarie F. Shepherd, Alissa J. Cooper, Adam J. Schoenfeld, Abraham J. Wu, Charles B. Simone +6 more

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events

medRxiv(2024)10.1101/2024.06.10.24308518

N/A

0DataRank · unranked

2 citations

Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cárdenas, Christina J. Falcon +13 more

67O Polygenic risk score associations with immune checkpoint inhibitors related endocrine toxicity

Annals of Oncology(2024)10.1016/j.annonc.2024.08.075

N/A

0DataRank · unranked

0 citations

Zoe Quandt, Ashis Saha, Lifen Yao, P. Midda, Yaomin Xu +15 more

A clinical benchmark of public self-supervised pathology foundation models

Nature Communications(2025)10.1038/s41467-025-58796-1

N/A

0DataRank · unranked

84 citations

Shengjia Chen, Manbir Singh, Ruchika Verma, Silke Muehlstedt, Jennifer Zeng +12 more

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-011273

N/A

0DataRank · unranked

7 citations

Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cárdenas, Christina J. Falcon +13 more

Allele-specific HLA LOH in solid tumors: distinct patterns by tumor type and potential prognostic relevance

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012435

N/A

0DataRank · unranked

5 citations

Christian Roy, Michael V. Gormally, Meagan Montesion, Patrick J. Halvey, Aastha Jindal +6 more

Multi-omics analysis reveals differential benefits of immunotherapy±chemotherapy based on detailed smoking history in advanced non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012205

N/A

0DataRank · unranked

1 citations

Biagio Ricciuti, Arielle Elkrief, Joao V Alessi, Alessandro Di Federico, Federica Pecci +11 more

Adam J. Schoenfeld

Indexed papers

Top data-sharing exemplar

Papers